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Abstract: Nipple sparing mastectomy (NSM) has quickly become an accepted technique for patients 
with selected cancers and for risk reducing surgery. Much of its surgical acceptance over the last decade 
has been based on the low risk of nipple areolar complex (NAC) occurrence in breast cancer patients. 
Improved patient satisfaction due to improved cosmetic outcomes with reconstruction have also driven 
its popularity. We reviewed current English journals to determine the NSM techniques which achieve the 
lowest complications, best outcomes, and best patient satisfaction. We researched studies showing reductions 
in complications with improved surgical techniques and patient selection which have been implicated in 
improved results. In the studies reviewed, incision placement, away from the nipple, resulted in the lowest 
rates of ischemic nipple complications and the best cosmetic outcomes. The effect of other factors such as 
surgeon experience and thickness of skin flap development were more difficult to prove. Leaving a 2–3 mm 
rim of tissue around the nipple bundle was shown to help preserve the nipple vascularity. Lower complication 
rates with improved outcomes and patient satisfaction were reported in the literature in patients with B or 
smaller cup sizes, non-smokers, and patients with lower body mass index (BMI). Incision placement, away 
from the nipple, with preservation of a 2–3 mm rim of tissue around the nipple bundle along with careful 
patient selection were the most significant variables reviewed which helped to lower complications rates of 
NSM. Coordinated surgical planning with the breast and plastic surgeons to determine the best surgical 
approach for each individual patient is necessary to obtain the best results. Although short-term oncologic 
follow-up seems to be acceptable, longer follow-up will still be needed to define the best breast cancer 
surgical candidates for the nipple sparing approach.
Keywords: Nipple sparing mastectomy technique; nipple sparing mastectomy complications; nipple sparing 
mastectomy cosmesis; nipple sparing mastectomy satisfaction; nipple sparing mastectomy incisions; nipple sparing 
mastectomy vascular supply
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Introduction
Less aggressive surgical management of breast cancer 
patients has made major advances over the last 3 decades 
with the rebuke of the Halstedian concept to acceptance of a 
more systemic approach to the management of breast cancer 
patients. Surgery has become more conservative starting 
with Bernie Fisher’s proven concept of breast conservation 
in the 1980’s and then the advent of sentinel lymph node 
(SLN) evaluations and skin sparing mastectomies in the 
1990’s. With studies proving the low risk of nipple areolar 
complex (NAC) involvement in select cancer patients (1-3) 
and the new genetic era of breast cancer risk, it was only 
natural that nipple sparing techniques would be developed 
in the late 1990’s and at the turn of the century. In 1999, 
Lynn Hartmann’s paper (4) in the NEJM showed the benefit 
for prophylactic, or better termed risk reducing nipple 
sparing mastectomy (NSM), in high risk patients with a 
90% reduction in breast cancer development. This first 
started the movement towards the nipple sparing approach. 
Meijers-Heijboer’s later study (5) in the NEJM along with 
other publications (6-9) then proved the advantages of risk 
reducing mastectomy in BRCA+ patients. These cancer 
reduction benefits along with the improved aesthetic 
outcome from optimal breast contouring with minimal 
scarring and improved patient satisfaction led to the NSM’s 
quick acceptance and implementation into breast surgery 
practices. 
The use of the NSM in cancer patients is more 
controversial and though it has become standard practice 
in many early stage cancer patients, who require or request 
a mastectomy, there are no controlled clinical trials 
evaluating its effectiveness. The initial use of the nipple 
sparing approach was spurred by evidence showing a low 
risk of NAC involvement in the pathological mastectomy 
specimens of smaller cancers (less than 2 cm) which are node 
negative, more peripherally located (>2 cm from the nipple), 
and localized (1-3) (Table 1). This led various institutions 
to begin performing NSMs in this well-defined lower risk 
group of breast cancer patients with good short-term cancer 
outcomes (10-13). This has now progressed to the expansion 
of eligibility criteria with some institutions advocating for 
its use in higher risk patients with larger tumors, tumors 
close to the nipple, or even in patients with more aggressive 
cancers after neoadjuvant chemotherapy (14). Its utilization 
has also increased with the greater use of mastectomy and 
contralateral prophylactic mastectomy (15,16) especially 
in the younger aged breast cancer population (17,18). To 
date, only one meta-analysis (19) has critically analyzed 
overall survival (OS), disease-free survival (DFS), and local 
recurrence (LR) in cancer patients who underwent NSM 
showing no significant differences compared to women 
undergoing modified radical mastectomy (MRM) or skin 
sparing mastectomy (SSM). This meta-analysis is limited 
in that it focuses mainly on short-term follow-up studies 
in earlier stage cancer patients. The American Society of 
Breast Surgeons (ASBS) currently has an on-going registry 
trial tracking NSM patients throughout the United States 
to help better define patient outcomes and eligibility criteria 
in the future.
In this review, we have attempted to search for the best 
studies of the NSM approach to determine the optimum 
technique with the lowest complication rates, trying 
to identify the technical causes of the most common 
complications and the best methods to avoid them. We 
focused on studies evaluating surgeon specific variables as 
well as patient variables which help to reduce post-operative 
complications. We only briefly mention the clinical 
oncologic indications for the procedure and cancer specific 
outcome data as well as specific reconstruction technique 
unless it had some bearing on overall complication or 
outcome since these topics are being described elsewhere in 
this journal edition.
Methods
We researched articles using MEDLINE and PubMed 
using the MeSH headings for “nipple sparing or total SSM, 
technique, complications, outcomes, or satisfaction”. We 
performed a world-wide search of all English language 
journals. We chose relevant articles which focused mainly 
on technical factors including complications and patient 
satisfaction.
Results
SLN biopsy in prophylactic surgery
The use of SLN biopsy in prophylactic surgery has been 
studied in at least three separate institutional studies 
showing the frequency of occult cancer in prophylactic 
mastectomy patients to be less than 10% with the majority 
of the occult cancers found to be ductal carcinoma in situ 
(DCIS) (20-22) (Table 2). The rate of occult invasive cancers, 
being less than 5%, does not justify the use of routine SLN 
biopsy for patients undergoing nipple sparing mastectomies 
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Table 1 Occult nipple areolar cancer involvement
Studies Years Number of mastectomy specimens Nipple areolar complex involvement (%)
Laronga et al. (1) 1999 246 5.6
Simmons et al. (3) 2002 217 10.6
Lagios et al. (2) 1979 149 30.2*
*, 95% of tumors <2.5 cm from the nipple.
Table 2 Incidence of breast cancer in prophylactic mastectomy specimens
Authors Institutions Study years
Number of 
patients
Number of invasive 
cancers (%)
Number of noninvasive 
cancers (%)
Soran et al. (22) UPMC 1999–2004 155 2 patients (1.3) 3 patients (1.9)
Black et al. (21) Mass General 1999–2005 173 5 patients (2.9) 14 patients (8.1)
Boughey et al. (20) MD Andersen 2000–2005 409 8 patients (2.0) 14 patients (3.4)
in the prophylactic setting.
Incision placement
Various incision locations have been described for NSMs 
with individual surgeons or institutions tending to favor 
certain approaches (23-27). The incisions used most 
frequently were best evaluated by Endara et al. (26) who 
analyzed 48 pooled NSM studies from the literature with 41 
studies describing the mastectomy incision and 11 studies 
evaluable for outcomes by incision type which found the 
most common incision used was a radial approach (46%) 
followed by the periareolar (27%), and the Inframammary 
incision (21%). The Endara et al. (26) study also looked 
at nipple necrosis rates associated with incision placement 
in the same 11 studies which included 543 procedures and 
found the lowest rates of nipple necrosis in the incisions 
involving the least circumference of the nipple (radial 
incision, 8.83%; inframammary, 9.09%; periareolar/
circumareolar, 17.81% and transareolar, 81.82%). Increased 
risk of nipple areolar necrosis associated with periareolar 
incisions was also seen in an Italian study by Salgarello 
et al. (28) where it was seen as an early complication in 4 of 
the breasts [9.5% (4/42) of total NSMs] with periareolar 
incisions but in none of the 22 breasts with radial incisions 
undergoing NSM from 2004 to 2009.
An earlier single institution study which evaluated 
incision location and nipple necrosis rates was performed 
at University of California, San Francisco (UC-SF) and 
published by Wijayanayagam et al. (29) and Garwood 
et al. (13) and reported two general types of incisions 
crossing either >30% of the NAC (NAC crossing, 
mastopexy, nipple free grafts) or <30% of the NAC 
(inframammary, radial, or lateral/inferolateral) (Figure 1). 
Patients were divided into 2 cohorts, an earlier group of 
64 NSM procedures from 2001 to 2005 where more NAC 
crossing incisions were performed vs. a later cohort of 106 
NSM procedures from 2005 to 2007 where fewer NAC 
crossing incisions were performed. There was a significant 
increase in nipple survival rates (80–95%, P=0.003) and 
decrease in necrotic complications (30–13%, P=0.01) in the 
later cohort. A further follow-up study by Warren Peled 
et al. (11) from UC-SF compared their first 100 NSM 
cases with the following 557 NSM cases and continued 
to show decreased complications involving both nipple 
and mastectomy flap necrosis as well as reductions in 
expander/implant loss which they again attributed to fewer 
NAC crossing incisions (mainly inframammary or limited 
superior areolar incisions) as well to reduced use of direct 
to implant reconstruction and the selective use of acellular 
dermal matrixes (ADMs) during reconstruction.
Overall cosmetic and satisfaction outcomes as related 
to incision types have been reported but not statistically 
analyzed by a few individual studies (23,25,30-33). A 
retrospective study by Djohan et al. (32) best evaluated 
cosmesis and patient satisfaction using postop questionnaires 
of 78 patients as well as independent observer opinions. 
Seventy-three percent of the patients stated that they would 
undergo the surgery again. Decreased nipple sensation/
arousal was the most common complaint followed by lateral 
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displacement of the nipple. Nipple displacement was felt 
to be related to the radial incision used for the majority of 
the NSMs and was related to scar contraction. A separate 
study by Wagner et al. (30) evaluated cosmetic outcomes 
of 26 patients who underwent NSM through independent 
evaluations by two plastic surgeons 6 months after surgery. 
There was an acceptable (excellent, very good, or good) 
appearance in the breasts of 73.1% of the patients and in 
the NAC of 55.8% of the patients. The biggest cosmetic 
problem was described as lateral displacement of the nipple 
in 67.4% of patients or lateral displacement of the breast 
in 50% of the patients and this was felt to be due to the 
lateral incision placements in the majority (79.6%) of the 
patients. Other single institution studies have suggested 
that keeping the incisions in the inframammary (25) or 
inferolateral (23,34) positions (away from the nipples) 
does not result in nipple lateralization and also offers 
better concealment of the incision. Moyer et al. (33) 
reported on a retrospective database evaluation of NSMs 
in 26 patients (40 NSMs) performed from 2009 to 2010 
where postoperative photographs were evaluated by four 
reviewers. Circumareolar incisions were associated with a 
Figure 1 Nipple sparing mastectomy incisions. (A,B,C,D) Incisions encompassing >30% of NAC: (A) circumareolar-free nipple grafting; 
(B) periareolar mastopexy; (C,D) nipple crossing. (E,F,G) incisions encompassing <30% of NAC: (E) inframammary; (F) inferolateral; (G) 
periareolar with or without lateral radial extension [reproduced with permission from Garwood et al. (13)]. NAC, nipple areolar complex.
A B C
D E F
G
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nipple necrosis rate of 75% compared with 33% for radial 
incisions and 27% for inframammary incisions and were 
related to worse aesthetic evaluations. Not one of these 
studies was set up to statistically evaluate the cosmesis and 
satisfaction rates of NSM independent of the incision type 
and they are just single institution observations.
Preserving the vasculature
The maintenance of the NAC viability and skin flap 
perfusion has been studied in past female breast cadaveric 
studies by van Deventer et al. (35) and O’dey et al. (36). 
The NAC gets the majority of its blood supply from the 
internal thoracic vessel with its medial perforators and the 
lateral thoracic vessel (Table 3). O’dey et al. (36) suggested 
that medial and lateral based pedicle flaps (superomedial 
and superolateral) may provide the best blood supply to 
the nipple which would favor a more inferior incision to 
preserve these pedicles. If a radial incision is used then a 
more lateral incision would be favored to help preserve as 
much of the internal thoracic blood supple coming off the 
medial flap as possible. A full-thickness glandular dermal 
skin flap dissection, leaving much of the subdermal fat, was 
also felt to be beneficial for vascular preservation as opposed 
to a thinner split-thickness lipo-dermal flap, where more of 
the subdermal fat is removed.
Preservation of the NAC 
We found no studies that were designed to determine 
exactly how to handle the thickness of tissue left under the 
NAC with different surgeons applying different techniques 
and strategies. Studies have not been specifically controlled 
to determine if either everting and coring the nipple to 
remove all the visible ductal tissue (27,29) vs. a more 
conservative approach of leaving a visible rim of tissue in 
and around the nipple and areola (24,37) leads to better 
nipple viability. Petit et al. (38) from Milan reported on 
follow-up at 5 years of 1,001 NSMs where ELIOT and 
intraoperative radiation, was applied to the retroareolar 
residual nipple tissue with excellent results (nipple necrosis 
rate of 3.5%). Another study from Rusby et al. (39) looked 
at the microscopic anatomy of the NAC in 7 non-irradiated 
and 5 irradiated nipples and found that removal of the duct 
bundle in the center of the nipple and leaving a 2 or 3 mm 
peripheral rim of subcutaneous tissue around the nipple 
removed 96% (2 mm) and 87% (3 mm) of the ductal tissue, 
respectively. The study also found that leaving a 2 or 3 mm 
peripheral rim of subcutaneous tissue around the nipple 
retains 50% (2 mm) and 66% (3 mm) of the vascularity of 
the nipple, respectively and that radiation did not affect 
the vascular density of the ductal tissue in the nipple. 
These individual institutional trials and studies give some 
experimental support to validate the concept of acceptable 
NAC viability yet good ductal tissue clearance with the 
technique of leaving small residual rims of retroareolar 
breast tissue during NSMs.
The use of a “delay phenomenon” by creating a surgical 
wound to improve the blood supply to the NAC prior to 
the NSM has also been described with good results (40,41). 
The procedure involves a periareolar incision to elevate a 
plane beneath the NAC 1–3 weeks before the planned NSM 
and thus stimulating improved blood supply to the wounded 
tissue. Jensen et al. (41) emphasized its use, without any 
NAC loss, in 20 patients with prior areolar incisions, 
significant ptosis, or smokers. In lower risk patients, where 
360° dermal perfusion could be preserved, however, its use 
was not felt necessary. 
Pathologic assessment of the NAC
Intraoperative pathologic evaluation of the NAC to 
Table 3 Contribution of chest wall arterial vasculature to the NAC with associated vascular pedicle territories
Arterial supply O’Dey et al. (36) (%) van Deventer (35) (%)
Internal thoracic artery: medial pedicle 86 100
Lateral thoracic artery: lateral pedicle 100 70
Anterior intercostal branches: medial and inferior pedicle 71 74
Thoracoacromial high thoracic artery: superior pedicle 57 7.4
Posterior intercostal branches: lateral and inferior pedicle N/A 4
NAC, nipple areolar complex; N/A, not available.
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determine preservation was initially a standard during all 
NSMs to determine, intraoperatively, if the NAC could be 
preserved in patients. This has recently been abandoned 
by some practices (24) due to rare instances of positive 
biopsies. Its use was also questioned in a poster from the 
ASBS registry (42) due to the low rates of intraoperative 
involvement (2/104 NAC biopsies) and 2 nipples removed 
due to false positive intraoperative results which were read 
as indeterminate or suspicious and were found to be cancer-
free after the nipples were removed intraoperatively. 
Tumescence
The use of tumescence as an aid in raising skin flaps 
to decrease bleeding using lactated ringers solution 
containing 1% lidocaine and dilute (1:1,000) epinephrine 
has been previously described for use in mastectomies (43). 
Tumescence was not shown to be an independent variable 
affecting post-operative complications including infection, 
flap necrosis, hematoma, seroma, or epidermolysis in two 
separate studies of non-NSMs performed by Khavanin 
et al. (44) and Abbott et al. (45). It has not been well studied 
in NSM patients and is currently being used as an aid in some 
institutions to decrease bleeding with sharp (scissor or knife) 
dissection to avoid electrocautery thermal injury to the skin 
but should be used with caution because of the temporary 
vasoconstrictive properties of the epinephrine. I could only 
find one paper which statistically evaluated tumescence in 
NSM but solely related to expander reconstruction in 966 
patients undergoing SSM and NSM (46) which found that 
tumescence was an independent risk factor associated with 
increased flap necrosis (12.8% with tumescence vs. 6.7% 
without) in those patients who had high intraoperative 
expander fill volumes (>66% maximal fill volume).
Surgeon experience
There is suggestive evidence and good reason to believe that 
surgical experience plays a role in reducing complications 
and improving outcomes in NSM but only one study 
performed by Gould et al. (47) specifically analyzed surgical 
experience with complications, specifically nipple necrosis 
rates. In this study, there was no significant reduction in 
nipple loss rates with surgeon experience of 1–2 cases 
(15%) vs. 3–10 cases (23%) vs. >10 cases (20%). This study, 
however, goes against other institutional experiences with 
larger numbers of cases showing improved complication 
rates as surgical experience and technique improves 
(13,24,27,32,34). Garwood et al. (13) in the 2-cohort study 
showed a significant decrease in necrotic skin complications 
(30% to 13%) and an improvement in nipple survival (80% 
to 95%) with a later cohort of NSM patients performed 
from 2005 to 2007 compared to an earlier cohort from 
2001 to 2005. A retrospective study by Colwell et al. (34) of 
500 consecutive NSMs from 2007 to 2012 showed a 5-year 
trend towards inferolateral/inframammary incisions with 
lower complication rates shown by multivariate analysis 
[odds ratio (OR), 0.018; 95% CI, 0.00260–0.12089] which 
helped to modified their subsequent incisions. Crowe et al. 
showed improvements in NAC viability comparing a 2004 
study (48) of 54 NSMs vs. a 2008 paper (27) of 149 NSMs 
with the later paper using only laterally and the earlier 
paper using medially placed incisions without NAC loss in 
their later experience.
Selection factors
Surgical selection criteria have to be considered when 
performing NSMs. Reviewed studies showed no difference 
in complication rates (30,47) or patient satisfaction rates (10) 
when the NSM was performed for cancer (therapeutic) 
or for prophylactic reasons. Bilateral NSM procedures 
compared to unilateral procedures, in the study by Wagner 
et al. (30), showed no increase in complication rates as well. 
A single institution retrospective review from 2003 to 2011 
by Gould et al. (47) comparing 113 NSM cases to a matched 
group of 120 SSM controls (28% vs. 27%) also found no 
significant differences in overall complication rates.
Patient specific selection criteria, however, does affect 
the outcome of NSMs. The effect of these patient specific 
variables on complication rates have not been well studied 
but has been best described by Gould et al. (47) in a 
series of 73 women who underwent NSMs from 2003 to 
2011. BMI, diabetes mellitus, hypertension (HTN), and 
smoking showed a nonsignificant trend towards worsening 
complications of nipple necrosis. Large bra cup size (C or 
larger) was the only statistically significant patient factor 
with a higher nipple necrosis rate of 34% compared to 
only 6% with B or smaller cup sizes. Djohan et al. (32), 
in his patient satisfaction survey of 78 NSM patients, 
also correlated lower patient satisfactions and increased 
complications with larger breasts and increased BMI. BMI, 
smoking and preoperative radiation were associated with 
higher total complication rates in the study by Colwell 
et al. (34) which evaluated 500 NSMs from 2007 to 2012. In 
the 2-cohort study by Garwood et al. (13) smoking was also 
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a statistically relevant independent variable associated with 
increased skin/nipple necrosis rates.
Reconstruction methods
Reconstruction method has also been linked to complications 
associated with NSM. Endara et al. (26) reported a 
pooled analysis study which compared 5 2-stage implant 
reconstruction studies vs. 5 direct to implant reconstruction 
studies vs. 2 autologous reconstruction studies and resulted 
in complication rates of 52.8%, 16.7%, and 23.7% 
with nipple necrosis rates of 4.5%, 4.1%, and 17.3%, 
respectively. Gould et al. (47) showed no significant effect 
of reconstruction type on nipple necrosis complications 
in the 113 NSM cases evaluated but there was a trend 
toward higher nipple necrosis rates with autologous vs. 
either 2-stage or direct to implant reconstructions (40% 
vs. 18.5%, P=0.23). In comparing the 2-stage vs. the direct 
to implant reconstruction, Colwell et al. (34) did not see a 
difference in complication rates in the 500 NSMs evaluated 
however, with experience they have developed selection 
criteria using the 2-stage reconstruction more selectively in 
patients at higher risk of nipple or skin flap necrosis (e.g., 
smokers, higher BMI). In Garwood et al.’s (13) 2-cohort 
study, a higher rate of necrotic skin complications resulted 
with immediate implant reconstruction in their initial 
cohort of NSM patients causing them to switch to 2-stage 
reconstructions in their later cohort of NSM patients with a 
reduction in the complication rate. In that study, autologous 
reconstruction still accounted for the highest skin necrosis 
complication rates of all of the reconstruction techniques 
(37% autologous complication rate vs. 18% for direct to 
implant vs. 7% for 2-stage reconstruction).
The inframammary nipple sparing technique (Figure 2)
Our initial experience and technique of NSM from 1988 to 
2007 including 67 patients has been previously described (49) 
wi th  the  major i ty  o f  our  procedures  per formed 
prophylactically (79%). We have now performed over 600 
NSMs with 95% performed by one breast surgeon (AYA) 
and one plastic surgeon (CAS). Since our initial paper, we 
have seen a significant increase in the numbers of NSMs 
performed for cancer as acceptance and eligibility has 
expanded.
Our technique involves a coordinated approach with our 
reconstructive surgeons especially as it relates to patient 
factors including comorbidities and breast size which have 
been shown to have significant impacts on outcomes. If 
large breast size or significant ptosis is felt to affect outcome, 
we have adopted Dr. Spear’s described technique (50) 
of a staged reduction mastopexy and delayed NSM, if the 
clinical situation allows. Previous augmentation, previous 
breast surgery, and even prior radiation have not been 
absolute contraindications for the procedure in our practice.
We perform MRI preoperatively in all our patients 
who are felt to be NSM candidates to rule out possible 
mammographic and ultrasound occult tumors in high-risk 
patients choosing risk reducing NSM and to determine 
eligibility of NSM in early breast cancer patients. We will 
allow multifocality as long as the tumors are >2 cm from the 
nipple and the disease is contained to one quadrant.
We begin by marking out symmetrical inframammary 
incisions with our plastic surgeon. The incision length 
varies from 8–11 cm depending on the breast anatomy 
in order to obtain appropriate exposure. Larger incisions 
can be required in some of the larger breasts or in 
patients with dense breast tissue where the skin is fairly 
taught. We have performed longer, more medially base 
inframammary incisions to allow for internal mammary 
artery access for deep inferior epigastric perforator (DIEP) 
flap reconstructions in selected cases. The incisions are 
planned to lie in the new inframammary fold as determined 
preoperatively by the reconstructive surgeons (usually about 
7.5–8.0 cm from the nipple). Once the incision is made, the 
superior skin flap is everted with the non-dominant hand 
and the breast tissue retracted inferiorly with two Adair 
clamps. The plane between the subcutaneous fat and the 
glandular tissue is developed to preserve the dermal blood 
supply. We have used sharp knife dissection but typically use 
the Peak PlasmaBladeTM radiofrequency device (Medtronic, 
Palo Alto, CA, USA). We do not use tumescence in order 
to prevent any short-term effect of vasoconstriction related 
to the epinephrine. Care must be taken while raising the 
initial inframammary flap below the nipple because this is 
the most ischemic part of the skin flap and surgeons often 
strip too much of the subcutaneous fat in this area exposing 
the dermal vessels to injury. The breast tissue is freed using 
this skin eversion technique past the posterior aspect of 
the NAC with only a small approximately 2–3 mm thick 
rim of breast tissue visibly left under the NAC. The nipple 
itself is not inverted and cored, in our technique, to prevent 
increased risks of nipple ischemia. Once the skin flap is 
developed to a plane where direct visualization is impossible 
by the skin eversion technique, lighted fiberoptic retraction 
(InvuityTM, Invuity, San Francisco, CA or LightMatTM, 
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Cura Surgical, Geneva, IL, USA) is used to visualize the 
plane superiorly up to the infraclavicular region, medially 
to the sternum, and laterally to the latissimus. Care is taken 
to preserve the intercostal perforators coming medially off 
the sternum which can supply a significant vascular supply 
to the skin flaps. Finally, electrocautery is used to remove 
the breast off the pectoralis major muscle. The axillary tail 
of the breast is the highest and most difficult to visualize, 
so this region is typically dissected last so as to use the 
countertraction of the breast to better visualize and remove 
these last breast/skin attachments. A retroareolar biopsy is 
then taken as a shave biopsy underneath the nipple and sent 
for intraoperative frozen section analysis and if positive for 
cancer, the NAC is removed through a separate horizontal 
elliptical incision during the same procedure. The breast 
tissue is often weighed by the plastic surgeons to help them 
determine the subsequent reconstruction volumes. The 
skin flaps are then visualized and trimmed, if necessary, to 
remove any residual breast tissue and to ensure even flaps. 
SLN biopsies are performed only in therapeutic cancer 
cases through a small separate axillary incision which can 
also be used to help visualize and assist in the removal of 
the axillary breast tissue. Tc99 is used alone without using 
either methylene blue or isosulfan blue dye to prevent 
the vasoconstriction associated with the blue dyes and 
potential effects on nipple viability. We use intraoperative 
Figure 2 Inframammary nipple sparing mastectomy technique. (A) Preoperative positioning and marking inframammary folds; (B) 
inframammary incision; (C) everting skin edges and beginning flap dissection; (D) flap dissection above the nipple with fiberoptic retractor; 
(E) dissection of breast off pectoralis muscle; (F) dissection of axillary breast tail; (G) retroareolar biopsy; (H) postoperative appearance after 
direct to implant reconstruction.
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skin angiography (SPY EliteTM, Novadaq, Ontario, Canada) 
in most of our cases at two separate time points, after the 
mastectomy and after the reconstruction to evaluate the 
skin flaps. There is limited data to quantify the absolute 
risk of skin flap necrosis with this device but we have found 
it helpful to identify possible areas of concern which we 
will monitor more closely. Since we use intraoperative 
skin angiography, we do not use tumescence since it causes 
significant vasoconstriction and poor visualization of the 
dermal vessels during angiography, making any predictions 
of skin/nipple viability nearly impossible. An upper body 
warmer (Bair HuggerTM, 3M, St. Paul, MN, USA) is 
kept on our patients for the first 24 hours to help prevent 
vasoconstriction. For post-operative pain control, we have 
used a variety of methods including Marcaine pumps (On-Q, 
Halyard Health, Irvine, CA, USA) placed subcutaneously 
under the skin flaps as well as pre-operative pectoral nerve 
blocks and more recently liposomal bupivacaine (ExparelTM, 
Pacira Pharmaceuticals, Parsippany, NJ, USA) injected into 
the pectoral muscle just prior to reconstruction.
Discussion
The concept and technique of NSM was originally 
described by Freeman in the 1960’s (51) but it was only 
described for high-risk patients since it was not accepted 
for cancer patients as the dogma of radical extirpation of 
cancer persisted up until the 80’s. As the BRCA gene was 
identified by Mary Claire King in the 1990’s, the NSM 
made a resurgence as an accepted procedure for high-risk 
patients with its reintroduction by Hartmann et al. (4) and 
later benefits reported in the BRCA population (5,6,8,52). 
The beginning of the century then saw the use of NSMs 
in cancer patients with some encouraging initial follow-up 
results (10,19,26,38,53,54) as measured by short term OS 
and LR rates. Of the papers with reasonable follow-up data, 
Endara et al. (26) reported locoregional recurrence rates 
(LRR) of 1.8% and distant metastasis rates (DM) of 2.2% in 
28 pooled studies but follow-up was short ranging from 0.2–
210 months and the tumor types and characteristics were 
not independently reported in the study. A meta-analysis 
reported by De La Cruz et al. (19) looked at eight studies 
comparing NSM with MRM/SSM with no statistically 
significant differences between the treatment groups in 
terms of use of adjuvant or neoadjuvant chemotherapy, 
use of adjuvant radiation, estrogen receptor (ER) or 
progesterone receptor (PR) status, human epidermal 
growth factor receptor 2 (HER2)/neu status, lymph node 
status or tumor sizes. Five of the 8 studies compared DFS 
with a 9.6% risk benefit for NSM, 5 studies compared OS 
with a 3.4% risk benefit for NSM, and 8 studies evaluated 
LR with a 0.4% benefit for NSM. None of these benefits 
for DFS, OS, or LR were statistically significant, however. 
Follow-up times ranged from 25 to 101 months. Gerber 
et al. (54) compared LRR, DM, and breast cancer specific 
death rates in a series of 238 patients from 1994–2000 who 
were candidates for MRM with tumors greater than 2 cm 
from the nipple and no skin involvement, and were then 
offered either SSM, NSM, or MRM. Forty-eight patients 
underwent SSM, 60 patients underwent NSM, and 130 
patients underwent MRM and no significant differences 
resulted after a mean follow-up of 101 months (LRR: 
10.4% SSM, 11.7% NSM, 11.5% MRM, P=0.974; DM: 
25% SSM, 23.3% NSM, 26.2% MRM, P=0.916; breast 
cancer specific death: 20.8% SSM, 21.7% NSM, 21.5% 
MRM, P=0.993). The largest prospective trial reporting 
outcomes of NSM for cancer at 13-year median follow-up 
was from the Karolinska Institutet in Sweden and reported 
by Benediktsson et al. (53). They followed 216 patients from 
1988 to 1994 who underwent unilateral NSM for a variety 
of cancers (13.3% DCIS, 33.3% stage I, 37.9% stage II, 
15.3% stage III) and showed a DFS of 51.3%, OS of 76.4%, 
LRR of 24.1%, and DM rate of 20.3%. The OS rates were 
considered acceptable compared to other Swedish trials 
of MRM at that time. The LRR was considered high and 
the follow-up of the patients who had a LRR (most had 
repeated local excisions and some with radiation therapy as 
well) showed no effect on their OS which is not the usual 
outcome for patients with recurrences after mastectomy. 
The Benediktsson study included a high percentage of 
patients with multifocality (73.6%), tumors >2 cm (35%), 
patients with positive lymph nodes (40.3%) and also used an 
older, less aggressive surgical technique for full breast tissue 
removal which may have also accounted for the higher LRR.
Cancer specific indications are not being specifically 
addressed in this paper but were available in many of the 
articles reviewed. There is no unanimity in the selection of 
cancer patients across many of the articles written on NSM. 
It can be argued however, that given the current available 
studies and lack of long-term cancer outcome, careful 
patient selection of patients undergoing NSM should 
be considered. These patients typically include isolated 
tumors <2.5 cm, >2 cm from the nipple, and without skin 
involvement.
During the initial introduction of NSM to both high-
risk and cancer patients, it was felt that complication 
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rates especially for skin/nipple necrosis would be too 
high to justify its use. It took time to implement its use in 
many programs but as the initial results began showing 
acceptable complication rates (Table 4), the technique took 
hold so that its use became universally accepted though 
individual selection criteria vary. Nipple and skin flap 
necrosis rates have typically fallen to rates between 5–10% 
with most being treated conservatively without full nipple 
loss. Complication rates have also fallen with improved 
experience and technical improvements as was seen in the 
papers by Garwood et al. (13) and Colwell et al. (34) where 
keeping the incisions away from the nipple (encompassing 
<30% of the NAC) and using inframammary incisions 
improved their complications. Better understanding of 
the NAC and skin flap blood supply as shown by O’dey 
et al. (36) and van Deventer (35) have also improved our 
ability to place incisions away from the major blood supply, 
the medial internal mammary artery, and have helped us 
understand the ability of the nipple to survive with minimal 
2–3 mm rims of residual periareolar tissue while still 
removing the majority of the ductal tissue.
Developing the skin flaps and preserving blood supply 
has also been enhanced by our understanding of the 
vascular anatomy but it should also be noted that there 
is significant patient variability in skin flap thickness 
required to adequately remove the majority of the breast 
tissue while preserving the dermal blood supply. Figure 3 
depicts a picture of two separate mammograms of two 
totally different patients where the skin flap thickness 
needs to be varied. A smaller lean patient will typically 
have a thin subdermal fat plane and thus require a thinner 
flap to remove all the breast tissue while maintaining the 
dissection in the glandular-dermal plane to keep the dermal 
vasculature intact. A larger patient can have a thicker 
subdermal fat plane, especially away from the NAC and care 
must be taken to not make the flap so thin that most of the 
subdermal fat is dissected away (lipo-dermal plane) which 
will remove more dermal vasculature and thus increase flap 
necrosis rates and complications.
The use of sharp (knife) vs. electrocautery dissection 
in raising the anterior skin flap is operator dependent. 
Sharp dissection often leads to increase blood loss and 
tumescence is often considered. Though there are no 
specific papers evaluating the risk of complications with 
NSM alone, tumescence has been used in NSM with 
acceptable outcomes (44). I personally like to use the peak 
PlasmaBladeTM (Medtronic, Palo Alto, CA, USA) and 
do not use tumescence while raising my skin flaps since 
the PlasmaBladeTM causes less thermal injury than the 
standard electrocautery due to a more precise area of action, 
especially when using the cutting function. I do not like 
the temporary vasoconstriction which occurs with the use 
of epinephrine with the use of tumescence. In my practice, 
we also use the SPY EliteTM (Novadaq, Ontario, Canada) 
intraoperative skin perfusion testing of the flaps after our 
mastectomies and after our reconstructions to evaluate our 
skin flap perfusion. This has helped us to better evaluate 
our surgical techniques in real time and gives us immediate 
feedback as to the vascular integrity of our flaps. Though 
there are few publications on its ability to predict flap 
necrosis in NSM (55), we find it a good qualitative perfusion 
test that has been able to help predict skin loss in virtually 
all our cases where it has occurred. The use of tumescence 
and associated vasoconstriction significantly affects the 
intraoperative perfusion testing, making the test difficult to 
interpret.
In the studies reviewed, patient selection factors 
had a significant effect on both cosmetic outcomes and 
complication rates. Most of the studies of NSM were highly 
selective in their patient populations and current smokers 
Table 4 Studies showing NSM complication rates
Study institution, year
Number of procedures 
[patients]
Complications [n (%)]
Hematoma Infection Flap necrosis Nipple necrosis Implant loss
UC-SF, 2012 (11) 657 [428] N/A 117 (17.8) 78 (11.9) 23 (3.5) 56 (9.9)
MSKCC, 2011 (12) 353 [200] 0 (0) 6 (2.0) 69 (19.5) 13 (3.5) 3 (1.0)
MD Anderson, 2012 (30) 54 [33] N/A 0 (0) 6 (10.0) 3 (5.6) N/A
Mass General, 2014 (34) 482 [267] 8 (1.7) 16 (3.3) 25 (5.2) 21 (4.4) 9 (1.9)
Milan, 2009 (38) 1,001 [1,001] N/A 20 (2.0) N/A 35 (3.5) 43 (4.3)
NSM, nipple sparing mastectomy; N/A, not available.
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as well as high BMI, large or ptotic breast, or patients 
with prior breast irradiation were excluded from NSMs 
(12,24,30,56). All of these factors seem to contribute to 
increased complications in the various studies reviewed 
which analyzed these patient factors (13,32,34,47) and 
should be carefully considered when selecting patients as 
candidates for NSM.
Overall cosmesis and patient satisfaction have been 
shown to be good to excellent in the NSM studies reviewed 
(10,28,31-33,54) and there are definite improvements 
seen in aesthetic outcomes in the studies comparing 
SSM with NSM (18,33). Complication rates have been 
shown to negatively affect satisfaction scores to a greater 
degree in prophylactic mastectomy patients as compared 
to the patients undergoing mastectomies for cancer (57). 
Dissatisfaction with nipple sensation and arousal scores 
associated with NSMs are common (32) though there have 
been no technical methods shown to improve these results. 
The only technical factors considered in the reviewed 
studies that helped improve nipple necrosis complications 
and patient cosmesis and satisfaction were incision 
placement away from the nipple which deceased nipple 
necrosis rates (33) and non-radial incisions which decreased 
nipple lateralization (28,32).
There have been several methods used to try to perform 
NSMs on larger or ptotic breasted women. We have 
preferred a staged reduction mastopexy procedure as 
described by Spear et al. (50), especially for prophylactic 
patients whose surgeries can be delayed. Full-thickness 
nipple grafting has also been used and is well described 
but is associated with increased nipple losses. Dietz 
et al. (58) has also described a unique technique of nipple 
preservation with a reduction procedure performed during 
the surgery and preserving the dermal vessels to the NAC 
by deepithelializing the surrounding skin of the nipple to 
perform the reduction yet preserve the NAC vasculature 
without a full-thickness graft.
The use of an endoscopic technique in performing 
NSMs for cancer patients has also been described by 
Sakamoto et al. (59,60) from Japan who uses a combination 
of an axillary and periareolar incision to perform the 
dissection off of the pectoralis fascia and the anterior skin 
flaps, respectively. The axillary incision is first used for the 
SLN biopsy. They had good results in their initial paper (59) 
including 87 patients from 2002 to 2005 but noted 
significantly higher rates of nipple necrosis with nipple 
coring (41%) vs. non-coring (18%) of the nipple. The 
follow-up paper from 2016 (60) included 404 patients and 
421 breasts with a very acceptable LRR of 2.6% after a 
median follow-up of 61 months. Age <40 years, stage III 
cancer, and inadequate surgical margins were significant 
variables associated with LRR.
Figure 3 Mammogram depiction of raising the glandular-dermal plane. (A) Patient with thin subdermal fat plane; (B) patient with thicker 
subdermal fat plane.
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In regards to reconstructive techniques, current studies 
would suggest that autologous reconstruction is associated 
with increased complication rates when performed 
with NSMs (13,26,47). Despite these initial concerns, 
autologous reconstruction has its benefits and should not 
be abandoned as an option in well selected patients. In our 
particular practice, direct to implant reconstruction has 
given excellent immediate cosmetic results in the majority 
of patients undergoing NSM with acceptable complication 
rates and can still be an option in larger or ptotic patients 
in combination with prior reduction mastopexy (50). It also 
has the added benefit of avoiding an unnecessary second 
procedure for the patient. We routinely use acellular 
dermal matrix (Alloderm, Allergan, Dublin, Ireland) for 
our direct to implant reconstructions and have not seen any 
specific increase in complication rates (61) and have even 
seen benefits in reduced capsular contracture rates, even in 
irradiated patients (62).
Conclusions
The technical aspects of NSM surgery vary from practice 
to practice in the literature and each surgeon has their 
own biases. The purpose of this review was by no means 
to endorse any one specific technique but to give an 
overview of the complexities of the surgery which exist 
and to offer certain principles and methods to help lower 
complications rates to get the best results from a standpoint 
of patient satisfaction and cancer outcome. The best take 
away information that can be gleamed from my personal 
experience and this literature review is that nipple viability 
can best be preserved by not encompassing more than 
30% of the nipple in any incision and keeping a 2–3 mm 
radius of tissue around the nipple bundle when performing 
the dissection underneath the nipple. The incision should 
be kept away from the nipple, preferably in the lateral or 
inferior aspects of the breast, to preserve the blood supply 
to the skin flaps and to offer the best cosmetic satisfaction 
results. Skin flaps need to be handled with care (blunt 
fiberoptic lighted retractors) and the anterior flap needs 
to be dissected in the glandular dermal plane, leaving as 
much of the subdermal fat intact (again to prevent vascular 
damage). This plane varies in thickness from patient to 
patient. The use of sharp dissection or electrocautery or the 
peak PlasmaBladeTM (Medtronic, Palo Alto, CA, USA) is at 
the discretion of the individual surgeon. Patient variables 
such as BMI, breast size, the need for postoperative 
radiation, and smoking must also be considered with 
changes in the technique such as staged reductions, the use 
of expanders, or even the decision to abandon a NSM and 
perform a SSM with removal of the nipple in select cases. 
Coordinated planning of the surgery with an experienced 
cancer and reconstructive team is of utmost importance to 
obtain the best patient outcomes. Continual monitoring of 
complication rates as well as cancer specific outcomes will 
also ensure the best quality of care for your patients.
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